查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861734

按自動化程度、最終用戶、材料類型、包裝類型、劑型和服務類型分類的全球醫藥合約包裝市場預測（2025-2032年）

Pharmaceutical Contract Packaging Market by Automation Level, End User, Material Type, Packaging Type, Dosage Form, Service Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，藥品合約包裝市場將成長至 704.9 億美元，複合年成長率為 9.21%。

關鍵市場統計數據
基準年 2024 348.2億美元
預計年份：2025年 381億美元
預測年份 2032 704.9億美元
複合年成長率 (%) 9.21%

將合約包裝的策略角色不斷演變，定位為在整個製藥產品組合中實現產品完整性、合規性和商業性差異化的關鍵組成部分。

醫藥合約包裝產業在臨床供應連續性、品牌保護和法規遵循方面佔據著至關重要的地位。近年來，包裝已從一種商品化服務演變為確保產品完整性、病患安全和市場差異化的策略要素。隨著製造商面臨日益複雜的生物製藥、組合產品和多元化的全球市場管道，他們的包裝合作夥伴必須在不斷擴展的材料和包裝規格選擇範圍內，提供精準、可追溯且靈活的包裝方案。

探索自動化、數位化可追溯性、材料創新和不斷變化的終端用戶需求如何融合，從而重新定義合約包裝策略和能力。

在整個醫藥包裝產業，變革正在重塑競爭格局和營運重點。從全自動化生產線到半自動化單元，自動化程度的不斷提高，在提升產能的同時，減少了人為錯誤，並加強了污染控制。同時，數位化和序列化技術正在重塑可追溯性能力，實現從填充到分銷的即時可視化，並支援更嚴格的防偽和供應鏈透明度監管要求。

評估到 2025 年關稅趨勢對包裝業務投入成本、籌資策略、合規負擔和資本配置的多方面影響

到了2025年，已宣布或實施的關稅累積效應為合約包裝業務帶來新的成本和策略複雜性。進口原料（包括玻璃、鋁、鋼和某些塑膠）關稅的提高推高了投入成本，迫使包裝相關企業重新評估其籌資策略和供應商關係。為此，許多公司加快了雙重採購的步伐，將採購轉向近岸供應商，並加強談判，以在遵守受限材料規格的同時保護利潤率。

基於全面細分的洞察揭示了自動化、最終用戶畫像、材料選擇、包裝、劑型和服務類型如何驅動策略重點和營運設計。

細分分析揭示了合約包裝生態系統中價值和風險集中的區域。了解這些層面有助於企業領導者優先考慮投資和夥伴關係。對自動化程度的評估揭示了兩種截然不同的營運模式：人工包裝，對於某些小批量或高度客製化的產品線仍然至關重要；以及自動化包裝，可提供規模化和一致性。在自動化領域，機器人系統可提供最佳的重複性，並為注射劑和易碎品提供無菌區域的優勢；而半自動化系統則在靈活性和成本之間取得了更好的平衡，適用於中等批量和二次包裝作業。

在美洲、歐洲、中東和非洲以及亞太地區進行區域差異化和能力優先排序，確保能力建構與法規環境和商業性現實相符。

區域趨勢正在塑造投資和產能擴張最具戰略價值的領域，而穩健的營運需要針對每個區域採取差異化的方法。在美洲，一體化的供應鏈、大規模的生物製藥研發管線以及完善的法規結構，催生了對先進的無菌填充和封裝能力、序列化合規性以及強大的二級和三級物流的需求。該地區也為近岸籌資策略提供了機遇，這些策略可以降低關稅風險，並有助於快速回應市場需求。

策略聯盟、垂直整合、專業化以及對品質系統和自動化的投資所驅動的競爭動態，正在推動對多樣化藥品包裝的需求。

整合、策略聯盟和能力專業化是主要企業活動中湧現的關鍵主題。合約包裝供應商正擴大與原料供應商、設備供應商和技術公司合作，以加快獲得先進的填充、貼標和序列化能力，同時控制資本密集度。這些聯盟也有助於快速部署已驗證的生物製藥和複雜劑型生產線。同時，一些公司正在尋求垂直整合，以獲得設計開發、序列化和可追溯性等附加價值服務，而另一些公司則專注於無菌注射劑、低溫運輸相容性和大批量泡殼包裝等細分專業領域，以保持營運效率。

切實可行的雙管齊下建議，旨在最佳化落地成本、加速產品序列化進程、規劃自動化投資，同時推動區域擴張和永續性舉措。

產業領導者應採取雙軌策略，兼顧短期韌性與長期能力建構。短期內，應優先最佳化落地成本，具體措施包括：重新設計供應商契約，納入符合關稅規定的條款；盡可能擴大雙重採購；以及對優質玻璃替代品和高性能塑膠實施材料再認證計劃，以評估其穩定性等效性。同時，應加快序列化和追蹤系統的實施，這些系統不僅要滿足監管要求，還要提供營運可視性，從而減少召回，提高退貨處理效率。

為了確保研究結果具有可操作性和有效性，我們採用了穩健的混合方法研究設計，整合了主要行業訪談、監管和技術審查、情境映射以及迭代專家檢驗。

本研究採用混合方法，結合了與主要相關利益者的對話、技術審查和跨職能檢驗。主要資料收集包括對包裝營運經理、供應鏈主管、品質和法規專家以及設備供應商進行結構化訪談，以確定營運限制、驗證方法和新的投資重點。次要分析參考了法規指南、關稅和技術標準，以評估合規性對材料和工藝的影響。設備和材料規格為自動化和材料權衡提供了技術框架。

將策略要務與採購韌性、模組化自動化、序列化和區域能力協調等重點相結合，以確保長期的營運和商業性優勢。

總之，合約包裝產業正處於一個轉折點，日益複雜的監管環境、波動的關稅以及技術的進步正在共同重塑競爭優勢。那些能夠透過策略採購和落地成本建模積極應對投入成本波動、投資模組化自動化以提高品質和產量、並整合端到端序列化和追蹤系統的企業，將更有能力滿足生物製藥開發商、品牌所有者和學名藥生產商不斷變化的需求。此外，根據管理體制和客戶詳細情形，按地區最佳化產能部署的策略將有助於降低風險並創造成長機會。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 為確保符合全球藥物監管法規，應擴大採用先進的序列化和可追溯性技術。
  • 製藥業的ESG（環境、社會和治理）措施正在推動對永續和可回收包裝材料的需求。
  • 拓展針對罕見疾病生物製藥和藥物小批量生產的個人化醫療包裝服務
  • 在低溫運輸產品的合約包裝生產線中整合物聯網感測器和即時監控解決方案
  • 投資自動化和機器人技術，以最佳化藥品包裝效率並降低營運成本。
  • 對於高風險藥品和鴉片類藥物而言，兒童安全防篡改包裝變得越來越重要。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依自動化程度分類的藥品合約包裝市場

  • 自動包裝
    • 機器人系統
    • 半自動系統
  • 手工包裝

9. 按最終用戶分類的藥品合約包裝市場

  • 生技公司
    • 生物製藥開發公司
    • 生物相似藥生產商
  • 品牌擁有者
    • 跨國企業
    • 當地公司
  • 非專利公司
    • 本地非專利公司

第10章：按材料類型分類的藥品合約包裝市場

  • 玻璃
    • I 型玻璃
    • II 型玻璃
    • 第三型玻璃
  • 金屬
    • 鋁
    • 鋼
  • 塑膠
    • 高密度聚苯乙烯
    • 聚對苯二甲酸乙二酯
    • 聚氯乙烯

第11章 依包裝類型分類的藥品合約包裝市場

  • 初級包裝
    • 安瓿
    • 泡殼包裝
    • 管瓶
  • 二級包裝
    • 紙盒
    • 托盤
  • 三級包裝
    • 調色盤
    • 收縮膜

第12章 依劑型分類的藥品合約包裝市場

  • 液體
    • 注射
    • 口服液
  • 半固態
    • 奶油
    • 凝膠
    • 軟膏
  • 固態劑型
    • 膠囊
    • 藥片

第13章：按服務類型分類的藥品合約包裝市場

  • 設計與開發
    • 概念設計
    • 原型
  • 灌裝/密封
    • 液體填充
    • 粉末填充
  • 標籤
    • 壓力敏感
    • 液體膠
  • 序列化和追蹤
    • 條碼
    • RFID標籤

第14章 各地區醫藥合約包裝市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 醫藥合約包裝市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國藥品合約包裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Catalent Pharma Solutions, LLC
    • PCI Pharma Services, Inc.
    • Sharp Packaging Services, Inc.
    • Aenova Holding GmbH
    • Recipharm AB
    • Almac Pharma Services Ltd
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • CordenPharma International Corp.
    • Siegried Holding AG
    • Ajinomoto Bio-Pharma Services, Inc.

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 為確保符合全球藥物監管法規，應擴大採用先進的序列化和可追溯性技術。
  • 製藥業的ESG（環境、社會和治理）措施正在推動對永續和可回收包裝材料的需求。
  • 拓展針對罕見疾病生物製藥和藥物小批量生產的個人化醫療包裝服務
  • 在低溫運輸產品的合約包裝生產線中整合物聯網感測器和即時監控解決方案
  • 投資自動化和機器人技術，以最佳化藥品包裝效率並降低營運成本。
  • 對於高風險藥品和鴉片類藥物而言，兒童安全防篡改包裝變得越來越重要。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依自動化程度分類的藥品合約包裝市場

  • 自動包裝
    • 機器人系統
    • 半自動系統
  • 手工包裝

9. 按最終用戶分類的藥品合約包裝市場

  • 生技公司
    • 生物製藥開發公司
    • 生物相似藥生產商
  • 品牌擁有者
    • 跨國企業
    • 當地公司
  • 非專利公司
    • 本地非專利公司

第10章：按材料類型分類的藥品合約包裝市場

  • 玻璃
    • I 型玻璃
    • II 型玻璃
    • 第三型玻璃
  • 金屬
    • 鋁
    • 鋼
  • 塑膠
    • 高密度聚苯乙烯
    • 聚對苯二甲酸乙二酯
    • 聚氯乙烯

第11章 依包裝類型分類的藥品合約包裝市場

  • 初級包裝
    • 安瓿
    • 泡殼包裝
    • 管瓶
  • 二級包裝
    • 紙盒
    • 托盤
  • 三級包裝
    • 調色盤
    • 收縮膜

第12章 依劑型分類的藥品合約包裝市場

  • 液體
    • 注射
    • 口服液
  • 半固態
    • 奶油
    • 凝膠
    • 軟膏
  • 固態劑型
    • 膠囊
    • 藥片

第13章：按服務類型分類的藥品合約包裝市場

  • 設計與開發
    • 概念設計
    • 原型
  • 灌裝/密封
    • 液體填充
    • 粉末填充
  • 標籤
    • 壓力敏感
    • 液體膠
  • 序列化和追蹤
    • 條碼
    • RFID標籤

第14章 各地區醫藥合約包裝市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 醫藥合約包裝市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國藥品合約包裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Catalent Pharma Solutions, LLC
    • PCI Pharma Services, Inc.
    • Sharp Packaging Services, Inc.
    • Aenova Holding GmbH
    • Recipharm AB
    • Almac Pharma Services Ltd
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • CordenPharma International Corp.
    • Siegried Holding AG
    • Ajinomoto Bio-Pharma Services, Inc.
Product Code: MRR-2A0283E25592

The Pharmaceutical Contract Packaging Market is projected to grow by USD 70.49 billion at a CAGR of 9.21% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 34.82 billion
Estimated Year [2025] USD 38.10 billion
Forecast Year [2032] USD 70.49 billion
CAGR (%) 9.21%

Framing the evolving strategic role of contract packaging as a mission-critical enabler of product integrity, compliance, and commercial differentiation across pharmaceutical portfolios

The pharmaceutical contract packaging sector occupies a pivotal position at the intersection of clinical supply continuity, brand protection, and regulatory compliance. Recent years have seen packaging evolve from a commoditized service to a strategic enabler of product integrity, patient safety, and market differentiation. As manufacturers grapple with increasingly complex biologics, combination products, and diversified global routes to market, packaging partners must deliver precision, traceability, and flexibility across a widening array of materials and formats.

Consequently, organizations that lead in integrating technology, quality systems, and supply chain resilience will set new performance baselines. This introduction frames the regulatory, operational, and strategic context that shapes current decision-making for contract packagers, brand owners, generics and biotechs alike. It highlights the imperative to adopt modular capabilities that accommodate diverse dosage forms, advanced serialization requirements, and evolving expectations around sustainability without compromising speed to market or compliance.

Exploring how automation, digital traceability, material innovation, and changing end-user demands are converging to redefine contract packaging strategies and capabilities

Across the pharmaceutical packaging landscape, transformative shifts are remaking competitive dynamics and operational priorities. Advances in automation, from fully robotic lines to semi-automated cells, are enabling higher throughput while reducing human error and improving contamination control. At the same time, digitalization and serialization technologies are reshaping traceability capabilities, enabling real-time visibility from filling to distribution and supporting stricter regulatory expectations for anti-counterfeiting and supply chain transparency.

Parallel to technological change, end-user demands are fragmenting. Biopharma innovators and biosimilars manufacturers require specialized sterile handling and cold-chain-compatible packaging, multinational brand owners seek consistent global labeling and branding controls, and regional and local generics prioritize cost efficiency and speed. Material innovation is also influencing design choices: glass types and metal alloys are being balanced against high-performance plastics according to stability, regulatory tolerance, and sustainability targets. Finally, service models are shifting toward integrated offerings that bundle design and development, filling, labeling, and serialization to provide single-source accountability and faster product commercialization timelines.

Assessing the multifaceted consequences of tariff developments through 2025 on input costs, sourcing strategies, compliance burdens, and capital allocation for packaging operations

The cumulative impact of tariff measures announced or implemented through 2025 has created a new layer of cost and strategic complexity for contract packaging operations. Increased duties on imported raw materials such as glass, aluminum, steel and certain plastics have elevated input costs and compelled packaging organizations to reassess sourcing strategies and supplier relationships. In response, many organizations accelerated dual-sourcing initiatives, shifted procurement toward nearer-shore suppliers, and intensified negotiations to preserve margin while maintaining compliance with regulatory material specifications.

These tariff-driven pressures have also influenced investment priorities. Firms that face sustained input-cost volatility have accelerated automation and efficiency programs to reduce unit labor cost and improve yield. At the same time, the reconfiguration of supply chains to avoid tariff exposure has led to higher inventory buffers in some regions and the selective relocation of critical production steps. Compliance considerations, including duty classification and documentation under the Harmonized Tariff Schedule and evolving trade enforcement practices, have obligated contract packagers to tighten import/export controls and to incorporate tariff risk into commercial terms. Consequently, procurement teams and commercial negotiators are increasingly embedding tariff clauses and landed-cost modeling into supplier contracts, while regulatory and quality teams work in parallel to ensure material substitutions meet stability and pharmacopoeial requirements.

Comprehensive segmentation-driven insights revealing how automation, end-user profiles, material choices, packaging formats, dosage forms, and service types determine strategic priorities and operational design

Segmentation analysis illuminates where value and risk concentrate across the contract packaging ecosystem, and understanding these strata helps leaders prioritize investments and partnerships. Evaluating automation level reveals two distinct operational cohorts: manual packaging operations that remain critical for certain low-volume or highly customized product lines, and automated packaging that delivers scale and consistency. Within automation, robotic systems offer the highest repeatability and sterile-zone benefits for injectable and sensitive formats, while semi-automated systems provide a balance of flexibility and cost for medium-volume runs and secondary packaging tasks.

End-user segmentation demonstrates how customer requirements drive service design. Biotech companies-differentiated between biopharma innovators and biosimilars manufacturers-demand high-touch, sterile handling and often bespoke packaging development. Brand owners, split into multinational companies and regional companies, require consistent labeling, global regulatory harmonization and scalable secondary and tertiary packaging solutions. Generic companies, represented by local generics, emphasize cost efficiency and rapid turnarounds. Material-type segmentation further refines operational choices: glass options such as Type I, II and III glass determine chemical inertness and shelf-life expectations; metal substrates, including aluminum and steel, provide barrier and mechanical strength for certain formats; and plastics-from high density polyethylene to polyethylene terephthalate and polyvinyl chloride-offer trade-offs among cost, barrier properties and sustainability profiles. Packaging type segmentation distinguishes primary formats like ampoules, blister packs and vials from secondary formats such as cartons and trays and from tertiary solutions including pallets and shrink wrap, each demanding different handling, labeling and unitization processes. Dosage-form segmentation separates liquid dosage into injectables and oral solutions, semi-solid forms into creams, gels and ointments, and solid dosage into capsules and tablets, which in turn determine filling technology, contaminant control, and packaging material compatibility. Service-type segmentation encapsulates design and development activities-concept design and prototyping-alongside filling and sealing for liquid and powder, labeling approaches that range from pressure sensitive to wet glue, and serialization and track and trace capabilities that include barcoding and RFID tagging, all of which together form end-to-end service bundles that customers expect when outsourcing packaging.

Regional differentiation and capacity prioritization across the Americas, Europe Middle East & Africa, and Asia-Pacific to align capabilities with regulatory and commercial realities

Regional dynamics are shaping where investment and capacity expansion will deliver the greatest strategic value, and a differentiated regional approach is necessary for resilient operations. In the Americas, integrated supply chains, large biologics pipelines, and established regulatory frameworks create demand for advanced sterile fill-finish capabilities, serialization compliance and robust secondary and tertiary logistics. This region also presents opportunities for near-shore sourcing strategies that mitigate tariff exposure and support rapid response to market demand.

Across Europe, the Middle East & Africa, regulatory harmonization and dense cross-border trade require flexible labeling and multilingual documentation management alongside sustainable packaging solutions that meet stringent environmental mandates. Companies operating here must balance centralized volume consolidation with localized packaging adaptations. In the Asia-Pacific region, fast-growing contract development and manufacturing ecosystems, combined with varied regulatory environments and competitive material supply chains, make cost-effective automation, scalable secondary packaging and rapid format changeovers essential. Each region therefore demands tailored commercial propositions, local supplier networks, and compliance architectures that align with regional regulatory regimes, logistics constraints, and customer expectations.

Competitive dynamics driven by strategic partnerships, vertical integration, specialization, and investments in quality systems and automation to capture diverse pharmaceutical packaging demands

Key company behaviors indicate consolidation, strategic partnerships, and capability specialization as dominant themes. Contract packaging providers are increasingly forming alliances with material suppliers, equipment vendors and technology firms to accelerate access to advanced filling, labeling and serialization capabilities while controlling capital intensity. Such partnerships also enable more rapid deployment of validated lines for biologics and complex dosage forms. Meanwhile, some firms pursue vertical integration to capture higher-margin services such as design and development or serialization and track-and-trace, while others focus on niche specialization-sterile injectables, cold-chain handling, or high-volume blister operations-to preserve operational efficiency.

Market leaders distinguish themselves through repeatable quality systems, regulatory expertise and robust validation protocols that reduce time-to-market for customers. They invest in workforce training to operate and maintain robotic and semi-automated cells, and they implement advanced analytics to monitor process performance, yield, and compliance. Emerging competitors differentiate on speed and price, leveraging modular lines and flexible staffing models to win smaller or regional contracts. Overall, competitive advantage accrues to companies that combine technical depth with commercial agility and the ability to deliver integrated service suites across design, fill-finish, labeling, and serialization.

Actionable dual-track recommendations to optimize landed cost, accelerate serialization, and sequence automation investments while expanding regional capability footprints and sustainability initiatives

Industry leaders should pursue a dual-track strategy that balances near-term resilience with long-term capability building. In the near term, prioritize landed-cost optimization by redesigning supplier contracts to include tariff contingency clauses, increasing dual-sourcing where feasible, and conducting material requalification programs that evaluate Type I glass alternatives and high-performance plastics for stability equivalence. Concurrently, accelerate the roll-out of serialization and track-and-trace systems that not only meet regulatory mandates but also provide operational visibility to reduce recalls and streamline returns.

For longer-term competitiveness, invest in a phased automation roadmap that sequences robotic systems for sterile and high-precision tasks while deploying semi-automated solutions for secondary packaging to preserve flexibility. Integrate design and prototyping capabilities to shorten development cycles and partner with equipment vendors on validation-ready solutions to reduce qualification timelines. Strengthen regional footprints by aligning capabilities to local regulatory realities and customer segments, and embed sustainability targets into material selection and tertiary unitization strategies. Finally, build a commercial model that offers modular service bundles-design and development, filling and sealing, labeling, serialization and track-and-trace-to capture a broader share of customer spend while providing single-source accountability for speed and quality.

Robust mixed-methods research design integrating primary industry interviews, regulatory and technical review, scenario mapping, and iterative expert validation to ensure actionable and defensible insights

This research employed a mixed-methods approach combining primary stakeholder engagement with secondary technical review and cross-functional triangulation. Primary data collection included structured interviews with packaging operations leaders, supply chain executives, quality and regulatory experts, and equipment providers to surface operational constraints, validation practices and emerging investment priorities. Secondary analysis drew from regulatory guidance, tariff schedules, and technical standards to assess compliance implications for materials and processes, while equipment and materials specifications provided the technical framing for automation and material trade-offs.

Analytical methods included scenario mapping to evaluate tariff-induced supply chain reconfigurations, capability gap analysis to identify where investments in automation and serialization yield the greatest operational returns, and segmentation analysis to align service offerings with customer types, dosage forms and packaging formats. Findings were validated through iterative expert review and by reconciling operational anecdotes with documented regulatory and technical requirements to ensure robustness. This methodology supports actionable insights while maintaining transparency on assumptions and the limitations inherent in rapidly changing trade and regulatory environments.

Synthesis of strategic imperatives emphasizing sourcing resilience, modular automation, serialization, and regional capability alignment to secure long-term operational and commercial advantage

In conclusion, the contract packaging sector stands at an inflection point where regulatory complexity, tariff dynamics, and technological advancement collectively redefine competitive advantage. Organizations that proactively address input-cost volatility through strategic sourcing and landed-cost modeling, that invest in modular automation to improve quality and throughput, and that embed end-to-end serialization and track-and-trace will be best positioned to serve the evolving needs of biopharma innovators, brand owners and generics manufacturers. Moreover, a regionally nuanced strategy that aligns capability deployment with regulatory regimes and customer segmentation will mitigate risk and unlock growth opportunities.

The path forward requires a disciplined focus on validated processes, workforce capability, and strategic partnerships that accelerate access to critical technologies and materials. By translating these insights into prioritized investments and operational changes, contract packagers and their customers can strengthen resilience, accelerate commercialization timelines, and protect product integrity across diverse markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of advanced serialization and traceability technologies to ensure compliance with global pharmacovigilance regulations
  • 5.2. Growing demand for sustainable and recyclable packaging materials driven by pharmaceutical industry ESG commitments
  • 5.3. Expansion of personalized medicine packaging services catering to small-batch biologics and orphan drug therapies
  • 5.4. Integration of IoT sensors and real-time monitoring solutions in contract packaging lines for cold chain products
  • 5.5. Investment in automation and robotics to optimize pharmaceutical packaging throughput and reduce operational costs
  • 5.6. Rising emphasis on child-resistant and tamper-evident packaging for high-risk medications and opioid products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Contract Packaging Market, by Automation Level

  • 8.1. Automated Packaging
    • 8.1.1. Robotic Systems
    • 8.1.2. Semi Automated Systems
  • 8.2. Manual Packaging

9. Pharmaceutical Contract Packaging Market, by End User

  • 9.1. Biotech Companies
    • 9.1.1. Biopharma Innovators
    • 9.1.2. Biosimilars Manufacturers
  • 9.2. Brand Owners
    • 9.2.1. Multinational Companies
    • 9.2.2. Regional Companies
  • 9.3. Generic Companies
    • 9.3.1. Local Generics

10. Pharmaceutical Contract Packaging Market, by Material Type

  • 10.1. Glass
    • 10.1.1. Type I Glass
    • 10.1.2. Type II Glass
    • 10.1.3. Type III Glass
  • 10.2. Metal
    • 10.2.1. Aluminum
    • 10.2.2. Steel
  • 10.3. Plastic
    • 10.3.1. High Density Polyethylene
    • 10.3.2. Polyethylene Terephthalate
    • 10.3.3. Polyvinyl Chloride

11. Pharmaceutical Contract Packaging Market, by Packaging Type

  • 11.1. Primary
    • 11.1.1. Ampoules
    • 11.1.2. Blister Packs
    • 11.1.3. Vials
  • 11.2. Secondary
    • 11.2.1. Cartons
    • 11.2.2. Trays
  • 11.3. Tertiary
    • 11.3.1. Pallets
    • 11.3.2. Shrink Wrap

12. Pharmaceutical Contract Packaging Market, by Dosage Form

  • 12.1. Liquid Dosage
    • 12.1.1. Injectable
    • 12.1.2. Oral Solutions
  • 12.2. Semi Solid
    • 12.2.1. Creams
    • 12.2.2. Gels
    • 12.2.3. Ointments
  • 12.3. Solid Dosage
    • 12.3.1. Capsules
    • 12.3.2. Tablets

13. Pharmaceutical Contract Packaging Market, by Service Type

  • 13.1. Design & Development
    • 13.1.1. Concept Design
    • 13.1.2. Prototyping
  • 13.2. Filling & Sealing
    • 13.2.1. Liquid Filling
    • 13.2.2. Powder Filling
  • 13.3. Labeling
    • 13.3.1. Pressure Sensitive
    • 13.3.2. Wet Glue
  • 13.4. Serialization & Track & Trace
    • 13.4.1. Barcoding
    • 13.4.2. RFID Tagging

14. Pharmaceutical Contract Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pharmaceutical Contract Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pharmaceutical Contract Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Catalent Pharma Solutions, LLC
    • 17.3.2. PCI Pharma Services, Inc.
    • 17.3.3. Sharp Packaging Services, Inc.
    • 17.3.4. Aenova Holding GmbH
    • 17.3.5. Recipharm AB
    • 17.3.6. Almac Pharma Services Ltd
    • 17.3.7. Vetter Pharma-Fertigung GmbH & Co. KG
    • 17.3.8. CordenPharma International Corp.
    • 17.3.9. Siegried Holding AG
    • 17.3.10. Ajinomoto Bio-Pharma Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GENERIC COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LOCAL GENERICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE I GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE II GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TYPE III GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY,